A recent study by AbbVie released in conjunction with the 2024 ASCO Annual Meeting used ConcertAI Patient360™ US dataset to assess biomarker testing disparities and their impact on overall survival. Results revealed disparities in testing rates and outcomes, particularly among different racial groups and treatment settings. Normalizing testing across race and treatment setting could potentially improve patient outcomes. More research is needed to confirm the impact of lack of biomarker testing on patient outcomes. Read the full study: https://hubs.ly/Q02BpfYV0 #LungCancerResearch #BiomarkerTesting #PatientOutcomes #HealthDisparities
ConcertAI’s Post
More Relevant Posts
-
Clinical Research Organization (CRO) | ProRelix Research - Offering World Class Services in Clinical Research, Clinical Data Management, Medical Writing and Pharmacovigilance.
The Role of Biomarker Discovery in Disease Management Discover the pivotal role of biomarker discovery in disease management, enhancing early detection, personalized treatment, and patient outcomes through cutting-edge research and technological advancements ✔ Improved Diagnostic Accuracy ✔ Enhanced Prognostic Prediction ✔ Personalized Treatment Plans ✔ Monitoring Disease Activity and Treatment Response ✔ Facilitating Drug Development and Approval Read more- https://lnkd.in/dYqV4WW6 🌐 Follow ProRelix Research: For a continuous stream of exciting developments, informative slides, and expert insights in the dynamic world of Clinical Research! 🌐 📊 #biomarkerdiscovery #diseasemanagement #healthcareinnovation #medicalresearch #precisionmedicine #healthtech #clinicalresearch #personalizedmedicine #biotech #diseaseprevention #biomarkers #medicalbreakthroughs #eahlthScience
To view or add a comment, sign in
-
🔬 Unlocking Insights in the NSCLC Market: Exploring Biomarkers and Drug Landscape 📊 🧬 Our latest infographic shows NSCLC biomarkers alongside their associated brands, providing a comprehensive overview of this dynamic market. From EGFR mutations to ALK rearrangements and beyond, Tudor Health EMR data decodes the complexities, enabling strategic decision-making in your healthcare initiatives. 🔍 Tudor Health EMR data analytics provides deep understanding of the NSCLC patient journeys. Our EMR data sheds light on the diverse patient populations and provider segments, empowering you to focus your efforts where they matter most. 💡 If you are interested in gaining valuable insights in the NSCLC market contact us at nsclc@tudorhealth.com.
To view or add a comment, sign in
-
The integration of digital technologies is reshaping healthcare as we know it, ushering in an era of personalised medicine and patient-centred care. And at the heart of this transformative journey lies companion diagnostics, poised to revolutionise disease diagnosis, monitoring, and treatment. Digital biomarkers enhance clinical trial design and drug development processes; so much so that with real-world data from a diverse patient population, researchers can gain a deeper understanding of how treatments work in different contexts leading to more targeted interventions and improved patient outcomes. Apply to join the round table discussion, featuring our CEO Ciara Clancy tomorrow, the 15th of February here: https://lnkd.in/etAcQUtK #digitalhealth #companiondiagnostics #futureofhealthcare
To view or add a comment, sign in
-
Bringing high quality patient data insights to pharma/bio companies. Using novel business models to improve data ROI. Enhancing use of novel drugs in niche diseases.
NSCLC patient data: Tudor Health captures patient data in all types of disease areas, especially complex areas with lots of longtail segments - and NSCLC is a perfect example of this. 20 biomarkers and over 40 approved brands make for a complex dataset - and we have it covered. #patientdata #emrdata #nsclc #
🔬 Unlocking Insights in the NSCLC Market: Exploring Biomarkers and Drug Landscape 📊 🧬 Our latest infographic shows NSCLC biomarkers alongside their associated brands, providing a comprehensive overview of this dynamic market. From EGFR mutations to ALK rearrangements and beyond, Tudor Health EMR data decodes the complexities, enabling strategic decision-making in your healthcare initiatives. 🔍 Tudor Health EMR data analytics provides deep understanding of the NSCLC patient journeys. Our EMR data sheds light on the diverse patient populations and provider segments, empowering you to focus your efforts where they matter most. 💡 If you are interested in gaining valuable insights in the NSCLC market contact us at nsclc@tudorhealth.com.
To view or add a comment, sign in
-
The Role of Biomarker Discovery in Disease Management Discover the pivotal role of biomarker discovery in disease management, enhancing early detection, personalized treatment, and patient outcomes through cutting-edge research and technological advancements ✔ Improved Diagnostic Accuracy ✔ Enhanced Prognostic Prediction ✔ Personalized Treatment Plans ✔ Monitoring Disease Activity and Treatment Response ✔ Facilitating Drug Development and Approval Read more- https://lnkd.in/dagmkDMW 🌐 Follow ProRelix Research: For a continuous stream of exciting developments, informative slides, and expert insights in the dynamic world of Clinical Research! 🌐 📊 #biomarkerdiscovery #diseasemanagement #healthcareinnovation #medicalresearch #precisionmedicine #healthtech #clinicalresearch #personalizedmedicine #biotech #diseaseprevention #biomarkers #medicalbreakthroughs #eahlthScience
To view or add a comment, sign in
-
Are your Hemophilia A treatment strategies keeping pace with the latest advancements? Uncover the paradigm shift in therapeutic approaches through our comprehensive discussion on novel high-sustained factor VIII replacement therapy and bispecific antibody non-factor replacement therapy. Dive into the science, scrutinize the clinical trial data, and join the conversation on optimizing treatment protocols for enhanced patient care. Elevate your practice today: https://ow.ly/Cin850QtJZ8 #CuttingEdgeCare #HemophiliaTherapeutics #LabToLife
To view or add a comment, sign in
-
The latest blog post by GRG Health highlights the significant strides in personalized medicine, particularly for patients who are either new to a condition or have not benefited from standard treatments. It discusses the importance of tailoring healthcare to individual genetic profiles, environmental factors, and lifestyles to enhance treatment efficacy. Innovations such as genetic testing, therapeutic drug monitoring, immunotherapy, and the use of biomarkers are transforming patient care by offering more targeted and effective treatment options. These advancements represent a promising shift towards more personalized, effective healthcare solutions for challenging cases. For more details, you can read the full post on GRG Health's website https://lnkd.in/duuK4ByP #PersonalizedMedicine #HealthcareInnovation #GeneticTesting #TreatmentAdvancements #BiomarkerResearch
To view or add a comment, sign in
-
Watch this video, where Prof. Sylvain Lehmann shares insights on the impact of biomarker diagnostics in #AlzheimersDisease and why a timely diagnosis is vital.¹⁻³ #ADPD24. For Healthcare professionals.
To view or add a comment, sign in
-
🤔 Struggling with patient recruitment? Retention? Delays? Thin budgets? RWD can: 1. Cut clinical trial cycle times by half ⌛ 2. Lower development cost 💰 3. Inform eligibility criteria 🔍 4. Enrich populations based on predicted response 👥 5. Select endpoints 🎯 6. Estimate sample size 📊 7. Understand disease progression 🔬 8. Enhance the diversity of participants 🌍 9. Show detailed insights into patients' experiences with diseases and treatments (even outside of clinical trials) 💉 10. Discover unmet patient needs 💡 11. Develop more effective therapies 💊 12. Reveal new phenotypes, disease markers, and biomarkers for patient identification and stratification 🧬 👉🏻 Data is a leg up for drug developers. And Rubix LS is at the forefront of empowering clinical leaders with RWD. #DrugDevelopment #MedicalInnovation #DrugDiscovery
To view or add a comment, sign in
-
Combining multi-omics data with individualized clinical patient data allows for a more comprehensive understanding of disease mechanisms and personalized treatment strategies. This integrative approach can lead to more precise diagnoses and targeted therapies tailored to each patient's unique biological profile. #molecularmedicine #moleculardiagnostics #moleculartesting #multiomics #omics #personalizedmedicine #precisionmedicine
To view or add a comment, sign in
38,141 followers